Stabilisation of ionic drugs through complexation with non-ionic and ionic cyclodextrins

被引:55
作者
Másson, M
Loftsson, T [1 ]
Jónsdóttir, S
Fridriksdóttir, H
Petersen, DS
机构
[1] Univ Iceland, Dept Pharm, IS-107 Reykjavik, Iceland
[2] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland
关键词
cyclodextrins; ionic drugs; complexation;
D O I
10.1016/S0378-5173(97)00387-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of negatively charged (i.e. carboxymethyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin), positively charged (i.e. trimerhylamoniumpropyl-beta-cyclodextrin) and neutral cyclodextrins (i.e. hydroxypropyl-beta-cyclodextrin, acetyl-beta-cyclodextrin and randomly methylated beta-cyclodextrin) on the chemical stability of various drugs were investigated. The degradation rate of each drug in aqueous cyclodextrin solutions was determined and the stability constant (K-c) of the drug-cyclodextrin complex and the degradation rate of the drug within the complex (k(c)) was obtained by non-linear fitting of the data. Compared to drug complexes with neutral cyclodextrins, the values of K-c were from 20 to 1600% larger when the drug and cyclodextrin molecules carried opposite charges, but from 50 to 80% smaller when the molecules carried the same type of charge. The values of k(c) were not affected by the charge of the cyclodextrin molecule. NMR studies of chlorambucil complexes indicated that the structure of the cyclodextrin complex was at least in some cases affected by the charge on the cyclodextrin molecules. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 14 条
[1]   Multiple modes for inclusion complexation between phenobarbital and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution [J].
Aki, H ;
Haraguchi, T ;
Niiya, T ;
Goto, Y ;
Yamamoto, M .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1996, 116 (10) :803-812
[2]  
Amidon G. L., 1986, CHEM STABILITY PHARM
[3]   EFFECT OF CYCLODEXTRIN DERIVATIVES ON INDOMETHACIN STABILITY IN AQUEOUS-SOLUTION [J].
BACKENSFELD, T ;
MULLER, BW ;
WIESE, M ;
SEYDEL, JK .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :484-490
[4]  
BREWSTER ME, 1989, J PARENT SCI TECHN, V43, P231
[5]  
CAPELLOS C, 1972, KINETIC SYSTEMS
[6]   Investigation of the alpha-cyclodextrin-myo-inositol phosphate inclusion complex by NMR spectroscopy and molecular modeling [J].
Crouzy, S ;
Fauvelle, F ;
Debouzy, JC ;
Goschl, M ;
Chapron, Y .
CARBOHYDRATE RESEARCH, 1996, 287 :21-35
[7]  
Fromming K. H., 1994, CYCLODEXTRINS PHARM, V5
[8]   CYCLODEXTRIN COMPLEXATION OF NSAIDS - PHYSICOCHEMICAL CHARACTERISTICS [J].
LOFTSSON, T ;
OLAFSDOTTIR, BJ ;
FRIORIKSDOTTIR, H ;
JONSDOTTIR, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 1 (02) :95-101
[9]  
LOFTSSON T, 1994, PHARMAZIE, V49, P292
[10]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025